Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group
L Del Mastro, M Venturini, R Lionetto, et al.
Anti-Cancer Drugs
|
March 1, 1997
Antiemetic efficacy of granisetron in patients with gynecological malignancies
P Sismondi, S Danese, G Giardina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1996
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)
P F Conte, E Baldini, G Gardin, et al.
Tumori
|
January 16, 1998
A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, Italy
E Baldini, G Gardin, P Giannessi, et al.
British Journal of Cancer
|
June 3, 2004
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety
E Baldini, T Prochilo, B Salvadori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest
P F Conte, M Bruzzone, F Carnino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1996
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer
M Venturini, A Michelotti, L Del Mastro, et al.
Gynecologic Oncology
|
June 1, 1997
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest
M Bruzzone, A Rubagotti, A Gadducci, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group
L Del Mastro, M Venturini, R Lionetto, et al.
Anti-Cancer Drugs
|
March 1, 1997
Antiemetic efficacy of granisetron in patients with gynecological malignancies
P Sismondi, S Danese, G Giardina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1996
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)
P F Conte, E Baldini, G Gardin, et al.
Tumori
|
January 16, 1998
A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, Italy
E Baldini, G Gardin, P Giannessi, et al.
British Journal of Cancer
|
June 3, 2004
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety
E Baldini, T Prochilo, B Salvadori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest
P F Conte, M Bruzzone, F Carnino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1996
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer
M Venturini, A Michelotti, L Del Mastro, et al.
Gynecologic Oncology
|
June 1, 1997
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest
M Bruzzone, A Rubagotti, A Gadducci, et al.
Page
of 5